Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


International Journal of Cancer Research and Treatment

Vol. 88, No. 3, 2015

Issue release date: February 2015

Add all to MyReading List
Clinical Study

Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients

Procopio G. · Testa I. · Verzoni E. · Iacovelli R. · Grassi P. · Galli G. · De Braud F. · Saravia D. · Salvioni R.
Oncology 2015;88:133-138 (DOI:10.1159/000367809)
Clinical Translational Research

Anti-Tumor Necrosis Factor Therapy Inhibits Lung Metastasis in an Osteosarcoma Cell Line

Kato H. · Wakabayashi H. · Naito Y. · Kato S. · Nakagawa T. · Matsumine A. · Sudo A.
Oncology 2015;88:139-146 (DOI:10.1159/000368414)
Clinical Study

Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer

Park J.S. · Rha S.Y. · Chung H.C. · Jung M. · Kim K.H. · Jun H.J. · Kim H. · An J.Y. · Kim H.-I. · Cheong J.-H. · Hyung W.J. · Noh S.H. · Kim H.S.
Oncology 2015;88:147-156 (DOI:10.1159/000368555)

Management and Characteristics of Patients with Metastatic Prostate Cancer in a Cohort of New Zealand Men

Lawrenson R. · Lao C. · Obertová Z. · Brown C. · Holmes M. · Tyrie L. · Scott N. · Fong P. · Laking G.
Oncology 2015;88:157-163 (DOI:10.1159/000368319)

A Phase I Study of UGT1A1 *28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI

Kim K.-P. · Hong Y.S. · Lee J.-L. · Bae K.S. · Kim H.-S. · Shin J.-G. · Lee J.S. · Kim T.W.
Oncology 2015;88:164-172 (DOI:10.1159/000368674)

Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma

Hassler M.R. · Sax C. · Flechl B. · Ackerl M. · Preusser M. · Hainfellner J.A. · Woehrer A. · Dieckmann K.U. · Rössler K. · Prayer D. · Marosi C.
Oncology 2015;88:173-179 (DOI:10.1159/000368903)

Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy

Durando X. · Dalenc F. · Abrial C. · Mouret-Reynier M.-A. · Herviou P. · Kwiatkowski F. · Chollet P. · Roche H. · Thivat E.
Oncology 2015;88:180-188 (DOI:10.1159/000367808)
Clinical Translational Research

Loss of Heterozygosity of PTEN (Encoding Phosphate and Tensin Homolog) Associated with Elevated HER2 Expression Is an Adverse Prognostic Indicator in Gastric Cancer

Zaitsu Y. · Oki E. · Ando K. · Ida S. · Kimura Y. · Saeki H. · Morita M. · Hirahashi M. · Oda Y. · Maehara Y.
Oncology 2015;88:189-194 (DOI:10.1159/000368984)